Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Bristol Myers Squibb Company (BMY) trades at a P/E ratio of 13.2×. Over the past ten years it has ranged from 0.0× (March 2025) to 259× (September 2018); the current reading is higher than 26% of that period. That is below the Drug Manufacturers General industry median of 24.5× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 15.6× —
FY2024 0.0× —
FY2023 13.6× (43.92%)
FY2022 24.2× 22.51%
FY2021 19.8× —
FY2020 0.0× —
FY2019 29.0× 69.31%
FY2018 17.2× (82.93%)
FY2017 101× 351.40%
FY2016 22.3× (69.71%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 12.7× (25.50%)
Mar 2026 17.0× 9.28%
Dec 2025 15.6× 2.66%
Sep 2025 15.2× (18.32%)
42 more quarters

Against its own ten years

Low 0.0× High 259×
Ten-year median 18.9×
Current reading's percentile 7

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
BMY Bristol Myers Squibb Company 13.2×
GSK GSK PLC Sponsored ADR compare 15.4×
SNY Sanofi compare 21.3×
NVS Novartis AG compare 22.6×
AZN AstraZeneca PLC compare 24.5×
AMGN Amgen Inc. compare 26.7×
PFE Pfizer Inc. compare 38.9×
Drug Manufacturers General industry median 24.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BMY